ACADIA Pharmaceuticals Earning Date (ACAD)

USA |NASDAQ |USD

ACAD Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 7, 2022 Sep 2022 $-0.21 - $-0.09
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 7, 2022 Sep 2022 $140.60M - $131.61M

Acadia Pharmaceuticals's next earnings date is Monday, Nov 7, 2022 for the fiscal quarter ending Sep 2022.

ACAD Earnings Date & History Chart

ACAD Earnings & Revenue Forecast

ACAD Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Sep 2022 20 $-0.21 $-0.31 $-0.10
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 20 $-1.38 $-1.59 $-1.22
Dec 2023 19 $-0.73 $-1.97 $0.61

ACAD Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Sep 2022 2 / 0 $-0.21 $-0.25 $-0.26
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 2 $-1.40 $-1.38 $-1.33
Dec 2023 3 / 5 $-0.70 $-0.65 $-0.62

ACAD Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Sep 2022 17 $140.60M $134.00M $148.82M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 20 $531.67M $519.20M $546.40M
Dec 2023 19 $666.41M $565.00M $923.00M

ACAD Earnings Date & Revenue History

ACAD Earnings History

|
Show More
Show More

ACAD Revenue History

|
Show More
Show More

Acadia Pharmaceuticals Next Earnings Date & Report

ACAD Next Earnings Date & Report Preview: Sep 2022 (FQ)

ACAD's next earnings date is Monday, Nov 7, 2022 for the fiscal quarter ending Sep 30, 2022.

According to analysts, the average EPS estimation for Acadia Pharmaceuticals's next quarterly earnings is $-0.21, with a low EPS estimation of $-0.31, and a high estimation of $-0.10.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-0.21, the last 2 month trend is $-0.25, and the 3 month trend is $-0.26.

Based on analysts, the average revenue estimation is $140.60M, with a low revenue estimation of $134.00M, and a high estimation of $148.82M.

Acadia Pharmaceuticals Previous Earnings Dates & Reports

ACAD Previous Earnings Date & Report Recap: Jun 2022 (FQ)

Acadia Pharmaceuticals's previous earnings date was Aug 2, 2022 for its fiscal quarter ended Jun 30, 2022.

ACAD Previous Earnings Date & Report Recap: Dec 2021 (FY)

Acadia Pharmaceuticals's previous annual earnings date was Feb 28, 2022 for its fiscal year ended Dec 31, 2021.

ACAD's earnings per share (EPS) was $-1.05, missing the consensus analysts forecast of $-1.02 by 2.94% , and higher than the previous year's EPS (Dec 2020) by -41.67%.

Revenues were $484.14M, worse than the forecast of $488.15M by -0.82%, and up by 9.60% from previous year's revenue.

The company reported a net income of $-167.87M.

Acadia Pharmaceuticals reported a free cash flow of $-126.78M for its fiscal year, compared to $-143.75M a year ago.

The company ended the fiscal year with $64.43M in total debt, an increase of 30.04% compared to the previous year.